{Reference Type}: Published Erratum
{Title}: Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
{Author}: Moreira TG;Matos KTF;De Paula GS;Santana TMM;Da Mata RG;Pansera FC;Cortina AS;Spinola MG;Baecher-Allan CM;Keppeke GD;Jacob J;Palejwala V;Chen K;Izzy S;Healey BC;Rezende RM;Dedivitis RA;Shailubhai K;Weiner HL;
{Journal}: Front Immunol
{Volume}: 12
{Issue}: 0
{Year}: 2021
{Factor}: 8.786
{DOI}: 10.3389/fimmu.2021.815812
{Abstract}: [This corrects the article DOI: 10.3389/fimmu.2021.709861.].